The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial.

The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial. J Clin Hypertens (Greenwich). 2005 Oct; 7(10):578-86.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antihypertensive Agents
Biphenyl Compounds
Blood Pressure
Diabetes Mellitus, Type 2
Dose-Response Relationship, Drug
Drug Combinations
Female
Humans
Hydrochlorothiazide
Hypertension
Male
Metabolic Syndrome
Middle Aged
Prospective Studies
Tetrazoles
Treatment Outcome

authors with profiles

George Bakris